Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.50

€2.50

8.700%
0.2
8.700%
€7.15
 
03.05.24 / Stuttgart Stock Exchange WKN: A3DNZ4 / Symbol: RGLS / Name: Regulus Therapeutics / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Regulus Therapeutics Inc. Stock

Regulus Therapeutics Inc. dominated the market today, gaining €0.20 (8.700%).
Currently there is a rather positive sentiment for Regulus Therapeutics Inc. with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 2.5 € the target price of 7 € shows a potential of 180.0% for Regulus Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Regulus Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Regulus Therapeutics Inc. in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -5.30%
Target price 8.303
Change
Ends at 25.03.25

Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 19.05%
Target price 5.509
Change
Ends at 18.03.25

Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 66.67%
Target price 8.410
Change
Ends at 19.09.24

Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Show more